Waldman, Todd

Requirement for p53 and p21 to Sustain G 2 Arrest After DNA Damage

Bunz, F., Dutriaux, A., Lengauer, C., Waldman, T., Zhou, S., Brown, J. P., Sedivy, J. M., Kinzler, K. W., & Vogelstein, B. (1998) · Science

Cancer-related Molecular PathwaysDNA Repair Mechanisms

Cited by 2,803

Disruption of p53 in human cancer cells alters the responses to therapeutic agents.

Bunz, F., Hwang, P. M., Torrance, C., Waldman, T., Zhang, Y., Dillehay, L., Williams, J., Lengauer, C., Kinzler, K. W., & Vogelstein, B. (1999) · Journal of Clinical Investigation

Cancer-related Molecular PathwaysGenetic factors in colorectal cancer

Cited by 1,044

Uncoupling of S phase and mitosis induced by anticancer agents in cells lacking p21

Waldman, T., Lengauer, C., Kinzler, K. W., & Vogelstein, B. (1996) · Nature

Cancer-related Molecular PathwaysDNA Repair Mechanisms

Cited by 728

Pharmacologic inhibition of histone demethylation as a therapy for pediatric brainstem glioma

Hashizume, R., Andor, N., Ihara, Y., Lerner, R., Gan, H., Chen, X., Fang, D., Huang, X., Tom, M. W., Ngo, V., et al. (2014) · Nature Medicine

Glioma Diagnosis and TreatmentChromatin Remodeling and Cancer

Cited by 476

Oncogenic Mutations of PIK3CA in Human Cancers

Samuels, Y., & Waldman, T. (2010) · Current Topics in Microbiology and Immunology

PI3K/AKT/mTOR signaling in cancerCancer Genomics and Diagnostics

Cited by 291

Identification of mutant K-Ras-dependent phenotypes using a panel of isogenic cell lines

Vartanian, S., Bentley, C., Brauer, M. J., Li, L., Shirasawa, S., Sasazuki, T., Kim, J.-S., Haverty, P., Stawiski, E., Modrusan, Z., et al. (2013) · Journal of Biological Chemistry

Protein Kinase Regulation and GTPase SignalingProtein Tyrosine Phosphatases

Cited by 65